Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

Joe Pleban, a CNU Alum, participated in snowboarding at the 2026 Paralympic Winter Games. (Joe Pleban) NEWPORT NEWS— Joe ...

The epidemiology of tumor lysis syndrome is evolving with the introduction of newer therapies. The occurrence of tumor lysis syndrome has become a less predictable but increasingly important aspect of ...

The discovery of a giant cell tumor in his cervical spine led Amsterdam baseball coach Robby Hisert to miss the 2025 season and undergo fusion surgery. He's back this year.

King told the outlet that her sister's cancer is "incurable" and that her sister is on medication for as much pain management as possible. She also said that doctors allegedly told Butler that her ...

Chimeric antigen receptor (CAR) T-cell therapy is an impactful treatment for blood cancers, such as leukemia and lymphoma. However, the immunotherapy has struggled against solid tumors, as tumor cells ...

Performances in N.Y.C. Advertisement Supported by Critic’s Pick In Mark Rosenblatt’s play, a powerful portrayal of the beloved children’s book author who almost gleefully exposes his bigotry. By Helen ...

A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered immunotherapy for solid tumors, according to a new study by Stanford Medicine ...

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now ...